Drug Information

Drug General Information
Drug ID
D0Y8JN
Former ID
DNC005048
Drug Name
2-(3-Methyl-indole-1-sulfonyl)-benzoic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527208]
Structure
Download
2D MOL

3D MOL
Formula
C16H13NO4S
Canonical SMILES
CC1=CN(C2=CC=CC=C12)S(=O)(=O)C3=CC=CC=C3C(=O)O
InChI
1S/C16H13NO4S/c1-11-10-17(14-8-4-2-6-12(11)14)22(20,21)15-9-5-3-7-13(15)16(18)19/h2-10H,1H3,(H,18,19)
InChIKey
FBAOKNXTXGWCMO-UHFFFAOYSA-N
PubChem Compound ID
44393556
Target and Pathway
Target(s) Fatty acid-binding protein, adipocyte Target Info Inhibitor [527208]
KEGG Pathway PPAR signaling pathway
NetPath Pathway TCR Signaling Pathway
Pathway Interaction Database AP-1 transcription factor network
Reactome Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis
Transcriptional regulation of white adipocyte differentiation
WikiPathways Lipid digestion, mobilization, and transport
Transcriptional Regulation of White Adipocyte Differentiation
References
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.
Ref 527208Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.